First-in-Human Safety, Tolerability, and Pharmacokinetics of Single-Dose Kukoamine B Mesylate in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase I Study

被引：0
|
作者：
Hongzhong Liu
Qian Zhao
Yuping Yuan
Zhenlei Wang
Teng Wang
Wei Tian
Wen Zhong
Ji Jiang
Shuai Chen
Kai Kong
Chunyan Jin
Pei Hu
机构：
[1] Peking Union Medical College Hospital,Clinical Pharmacology Research Center, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK and PD Investigat
[2] Chinese Academy of Medical Sciences & Peking Union Medical College,Clinical Research Center for Innovative Drugs
[3] Tianjin Chasesun Pharmaceutical Co.,undefined
[4] Ltd.,undefined
来源：
Infectious Diseases and Therapy | 2024年 / 13卷
关键词：
Kukoamine B; Phase I trial; Pharmacokinetic; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：361 / 371
页数：10
相关论文
共 50 条
  • [31] Correction to: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
    Lesley Taylor
    Barry Gidal
    Graham Blakey
    Bola Tayo
    Gilmour Morrison
    CNS Drugs, 2019, 33 : 397 - 397
  • [32] Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose denosumab in healthy Chinese volunteers: A randomized, single-blind, placebo-controlled study
    Chen, Qian
    Hu, Chaoying
    Liu, Yanmei
    Song, Rong
    Zhu, Wenjing
    Zhao, Hongxin
    Nino, Antonio
    Zhang, Fan
    Liu, Yun
    PLOS ONE, 2018, 13 (06):
  • [33] First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults
    Venishetty, Vinay Kumar
    Lecot, Jean
    Nguyen, Amanda
    Zhang, Jie
    Prince, William T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (09)
  • [34] A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects
    Yang, Haijing
    Wang, Peipei
    Li, Xin
    Wei, Qiong
    Yu, Jicheng
    Wu, Xiaojie
    Huang, Ying
    Li, Ruowan
    Du, Weijuan
    Zeng, Shaoqing
    Wu, Hailan
    Wang, Shuhai
    Zhang, Jing
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (02)
  • [35] Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study
    Valérie Bourdès
    Peter Dogterom
    André Aleman
    Pierre Parmantier
    Damien Colas
    Sighild Lemarchant
    Sébastien Marie
    Thomas Chou
    Khalid Abd-Elaziz
    Yann Godfrin
    Neurology and Therapy, 2022, 11 : 1353 - 1374
  • [36] Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study
    Bourdes, Valerie
    Dogterom, Peter
    Aleman, Andre
    Parmantier, Pierre
    Colas, Damien
    Lemarchant, Sighild
    Marie, Sebastien
    Chou, Thomas
    Abd-Elaziz, Khalid
    Godfrin, Yann
    NEUROLOGY AND THERAPY, 2022, 11 (03) : 1353 - 1374
  • [37] Safety and pharmacokinetics of the nonnucleoside polymerase inhibitor, HCV-796: Results of a randomized, double-blind, placebo-controlled, ascending single-dose study in healthy subjects
    Chandra, P.
    Raible, D.
    Moyer, L.
    Harper, D.
    Speth, J.
    Villano, S.
    Fruncillo, R.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S208 - S209
  • [38] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Camilo, Juan
    Ferreira, Arjona
    GASTROENTEROLOGY, 2016, 150 (04) : S537 - S538
  • [39] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Ferreira, Juan Camilo Arjona
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
  • [40] PHARMACOKINETICS OF LACOSAMIDE IN KOREAN HEALTHY SUBJECTS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE AND REPEATED DOSE STUDY.
    Gu, N.
    Kim, B. H.
    Lee, S.
    Kim, T. E.
    Fichtner, A.
    Elshoff, J.
    Yu, K. S.
    King, I. J.
    Shin, S. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S84 - S85
12345